Seeking Alpha

Allergan (AGN -3.5%) dips after its Q3 swung to a profit on strong specialty pharmaceutical...

Allergan (AGN -3.5%) dips after its Q3 swung to a profit on strong specialty pharmaceutical sales, but the company's issues cautious Q4 guidance below Street estimates. It now forecasts current-quarter earnings of between $0.97 - $0.99 per share on sales of $1.33B to $1.41B, below analysts expectations for an EPS of $1.01 on revenue of $1.41B.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|